Hims & Hers Health (HIMS) Insider Trading & Ownership $27.80 -0.14 (-0.49%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hims & Hers Health (NYSE:HIMS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.71%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.08 MNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$70.82 M Get HIMS Insider Trade Alerts Want to know when executives and insiders are buying or selling Hims & Hers Health stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HIMS Insider Buying and Selling by Quarter Hims & Hers Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/13/2025Oluyemi OkupeCFOSell11,581$24.44$283,039.64 1/10/2025Michael ChiInsiderSell7,259$24.07$174,724.13 1/6/2025Soleil BoughtonInsiderSell268,932$27.75$7,462,863.00 12/26/2024Oluyemi OkupeCFOSell4,213$29.98$126,305.74 12/24/2024Michael ChiInsiderSell17,303$27.97$483,964.91 12/20/2024Oluyemi OkupeCFOSell18,959$25.77$488,573.43 12/19/2024Michael ChiInsiderSell7,500$26.00$195,000.00 12/16/2024Andrew DudumCEOSell78,127$29.62$2,314,121.74 12/16/2024Irene BecklundInsiderSell472$29.58$13,961.76 12/10/2024Melissa BairdCOOSell85,561$31.01$2,653,246.61 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/10/2024Michael ChiInsiderSell7,259$32.25$234,102.75 12/2/2024Andrew DudumCEOSell33,513$33.38$1,118,663.94 12/2/2024Michael ChiInsiderSell2,054$33.56$68,932.24 11/26/2024Soleil BoughtonInsiderSell2,343$29.90$70,055.70 11/25/2024Oluyemi OkupeCFOSell101,993$29.62$3,021,032.66 11/18/2024Irene BecklundInsiderSell472$19.42$9,166.24 11/18/2024Melissa BairdCOOSell58,750$21.04$1,236,100.00 11/14/2024Anja ManuelDirectorBuy1,000$24.50$24,500.00 11/13/2024Oluyemi OkupeCFOSell142,886$29.93$4,276,577.98 11/12/2024Anja ManuelDirectorBuy4,000$26.94$107,760.00 11/6/2024Patrick Harrison CarrollInsiderSell15,000$22.07$331,050.00 11/5/2024Andrew DudumCEOSell188,888$20.88$3,943,981.44 10/29/2024Soleil BoughtonInsiderSell2,339$23.16$54,171.24 10/25/2024Michael ChiInsiderSell17,304$22.00$380,688.00 10/21/2024Michael ChiInsiderSell7,500$22.20$166,500.00 10/15/2024Soleil BoughtonInsiderSell2,339$20.41$47,738.99 10/14/2024Oluyemi OkupeCFOSell269,739$20.31$5,478,399.09 10/7/2024Melissa BairdCOOSell58,750$19.57$1,149,737.50 10/7/2024Oluyemi OkupeCFOSell9,868$19.96$196,965.28 9/20/2024Andrew DudumCEOSell45,767$16.33$747,375.11 9/20/2024Oluyemi OkupeCFOSell12,651$16.79$212,410.29 9/17/2024Soleil BoughtonInsiderSell2,339$16.50$38,593.50 9/4/2024Melissa BairdCOOSell11,749$14.65$172,122.85 9/3/2024Andrew DudumCEOSell188,888$14.56$2,750,209.28 9/3/2024Oluyemi OkupeCFOSell11,609$14.60$169,491.40 9/3/2024Soleil BoughtonInsiderSell2,345$14.65$34,354.25 8/27/2024Christiane PendarvisDirectorSell7,000$15.15$106,050.00 8/16/2024Irene BecklundInsiderSell472$15.66$7,391.52 8/6/2024Melissa BairdCOOSell16,784$17.00$285,328.00 8/6/2024Soleil BoughtonInsiderSell2,334$17.30$40,378.20 Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy.8/5/2024Andrew DudumCEOSell188,888$16.47$3,110,985.36 8/1/2024Michael ChiInsiderSell2,054$22.00$45,188.00 7/23/2024Soleil BoughtonInsiderSell2,335$20.29$47,377.15 7/16/2024Irene BecklundInsiderSell472$23.23$10,964.56 7/12/2024Michael ChiInsiderSell9,313$22.00$204,886.00 7/9/2024Melissa BairdCOOSell17,625$20.42$359,902.50 7/9/2024Soleil BoughtonInsiderSell2,335$20.28$47,353.80 7/5/2024Melissa BairdCOOSell17,625$20.51$361,488.75 7/3/2024Andrew DudumCEOSell188,888$20.75$3,919,426.00 6/25/2024Oluyemi OkupeCFOSell11,546$22.21$256,436.66 6/24/2024Michael ChiInsiderSell17,303$22.07$381,877.21 6/20/2024Andrew DudumCEOSell45,755$22.97$1,050,992.35 6/20/2024Michael ChiInsiderSell7,500$24.50$183,750.00 6/17/2024Irene BecklundInsiderSell472$24.10$11,375.20 6/6/2024Oluyemi OkupeCFOSell98,635$21.42$2,112,761.70 6/4/2024Andrew DudumCEOSell188,888$19.88$3,755,093.44 6/4/2024Melissa BairdCOOSell17,625$20.42$359,902.50 5/30/2024Soleil BoughtonInsiderSell129,667$20.55$2,664,656.85 5/28/2024Soleil BoughtonInsiderSell2,502$17.33$43,359.66 5/22/2024Christopher D PayneDirectorBuy110,000$17.74$1,951,763.00 5/20/2024Soleil BoughtonInsiderSell4,915$20.01$98,349.15 5/17/2024Irene BecklundinsiderSell943$14.50$13,673.50 5/13/2024Christiane PendarvisDirectorSell4,000$12.33$49,320.00 5/13/2024Soleil BoughtonInsiderSell2,503$12.33$30,861.99 5/9/2024Patrick Harrison CarrollInsiderSell10,000$13.00$130,000.00 5/2/2024Melissa BairdCOOSell11,750$12.08$141,940.00 5/1/2024Andrew DudumCEOSell188,888$12.54$2,368,655.52 4/29/2024Soleil BoughtonInsiderSell2,503$12.56$31,437.68 4/15/2024Soleil BoughtonInsiderSell2,503$13.95$34,916.85 4/8/2024Melissa BairdCOOSell11,751$14.74$173,209.74 4/5/2024Melissa BairdCOOSell11,751$14.58$171,329.58 4/4/2024Andrew DudumCEOSell188,888$14.97$2,827,653.36 4/1/2024Soleil BoughtonInsiderSell2,503$15.65$39,171.95 3/20/2024Andrew DudumCEOSell50,361$16.34$822,898.74 3/20/2024Oluyemi OkupeCFOSell9,912$15.82$156,807.84 3/19/2024Lynne Chou O'keefeDirectorSell10,044$15.52$155,882.88 3/18/2024Irene BecklundInsiderSell472$14.70$6,938.40 3/13/2024Soleil BoughtonInsiderSell63,621$15.17$965,130.57 3/7/2024Irene BecklundInsiderSell2,747$14.19$38,979.93 3/6/2024Melissa BairdCOOSell11,751$13.99$164,396.49 2/27/2024Irene BecklundInsiderSell2,747$12.08$33,183.76 2/13/2024Andrew DudumCEOSell97,208$9.58$931,252.64 2/12/2024Oluyemi OkupeCFOSell31,363$10.03$314,570.89 2/12/2024Soleil BoughtonInsiderSell22,839$10.03$229,075.17 2/9/2024Oluyemi OkupeCFOSell8,509$10.03$85,345.27 2/9/2024Soleil BoughtonInsiderSell4,080$10.03$40,922.40 1/29/2024Andrew DudumCEOSell15,100$9.01$136,051.00 1/25/2024Andrew DudumCEOSell127,688$9.08$1,159,407.04 (Data available from 1/1/2013 forward) HIMS Insider Trading Activity - Frequently Asked Questions Who is on Hims & Hers Health's Insider Roster? The list of insiders at Hims & Hers Health includes Alex Bard, Andrew Dudum, Anja Manuel, Christiane Pendarvis, Christopher D Payne, David B Wells, Irene Becklund, Jules A Maltz, Lynne Chou O'keefe, Melissa Baird, Michael Chi, Oluyemi Okupe, Patrick Harrison Carroll, and Soleil Boughton. Learn more on insiders at HIMS. What percentage of Hims & Hers Health stock is owned by insiders? 17.71% of Hims & Hers Health stock is owned by insiders. Learn more on HIMS's insider holdings. Which Hims & Hers Health insiders have been buying company stock? The following insiders have purchased HIMS shares in the last 24 months: Anja Manuel ($132,260.00), and Christopher D Payne ($1,951,763.00). How much insider buying is happening at Hims & Hers Health? Insiders have purchased a total of 115,000 HIMS shares in the last 24 months for a total of $2,084,023.00 bought. Which Hims & Hers Health insiders have been selling company stock? The following insiders have sold HIMS shares in the last 24 months: Alex Bard ($5,775,000.00), Andrew Dudum ($32,602,741.17), Christiane Pendarvis ($155,370.00), David B Wells ($977,000.00), Irene Becklund ($632,300.17), Lynne Chou O'keefe ($634,057.88), Melissa Baird ($9,069,613.77), Michael Chi ($2,519,613.24), Oluyemi Okupe ($17,531,350.23), Patrick Harrison Carroll ($461,050.00), and Soleil Boughton ($13,321,133.59). How much insider selling is happening at Hims & Hers Health? Insiders have sold a total of 4,870,731 Hims & Hers Health shares in the last 24 months for a total of $83,679,230.05 sold. Hims & Hers Health Key ExecutivesMr. Andrew Dudum (Age 35)Co-Founder, Chairman & CEO Compensation: $1.98M6 recent tradesMr. Yemi Okupe (Age 38)Chief Financial Officer Compensation: $1.01M9 recent tradesMs. Melissa Baird (Age 46)Chief Operating Officer Compensation: $1.05M5 recent tradesMs. Soleil Teubner Boughton (Age 45)Chief Legal Officer & Corporate Secretary Compensation: $928.7kDr. Patrick Carroll M.D. (Age 66)Chief Medical Officer, Member of Medical Advisory Board & Director Compensation: $54kMr. Mike Chi (Age 44)Chief Commercial Officer Compensation: $998kMs. Irene A. Becklund (Age 39)Senior VP, Controller & Principal Accounting Officer Compensation: $361.12k3 recent tradesMs. Khobi BrooklynChief Communications OfficerMs. Amee ParekhSenior Vice President of Human ResourcesDr. Peter Stahl M.D.Senior VP & Member of Medical Advisory Board More Insider Trading Tools from MarketBeat Related Companies NTRA Insider Trading FMS Insider Trading OPCH Insider Trading GH Insider Trading RDNT Insider Trading SHC Insider Trading BTSG Insider Trading VCYT Insider Trading LFST Insider Trading PRVA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NYSE:HIMS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
